FR2493702B1 - - Google Patents

Info

Publication number
FR2493702B1
FR2493702B1 FR8121017A FR8121017A FR2493702B1 FR 2493702 B1 FR2493702 B1 FR 2493702B1 FR 8121017 A FR8121017 A FR 8121017A FR 8121017 A FR8121017 A FR 8121017A FR 2493702 B1 FR2493702 B1 FR 2493702B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8121017A
Other languages
French (fr)
Other versions
FR2493702A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of FR2493702A1 publication Critical patent/FR2493702A1/fr
Application granted granted Critical
Publication of FR2493702B1 publication Critical patent/FR2493702B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8121017A 1980-11-10 1981-11-10 Compositions antivirales contenant des derives d'acide aminosulfonylhalogenobenzoique Granted FR2493702A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55157971A JPS5817167B2 (ja) 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物
JP56096376A JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
FR2493702A1 FR2493702A1 (fr) 1982-05-14
FR2493702B1 true FR2493702B1 (US07923587-20110412-C00022.png) 1984-10-12

Family

ID=26437582

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8121017A Granted FR2493702A1 (fr) 1980-11-10 1981-11-10 Compositions antivirales contenant des derives d'acide aminosulfonylhalogenobenzoique

Country Status (4)

Country Link
JP (2) JPS5817167B2 (US07923587-20110412-C00022.png)
DE (1) DE3144689A1 (US07923587-20110412-C00022.png)
FR (1) FR2493702A1 (US07923587-20110412-C00022.png)
GB (1) GB2090136B (US07923587-20110412-C00022.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000013A1 (en) * 1980-11-10 1983-01-06 Mochida Pharm Co Ltd Medicinal composition having an antiviral effect
JPS58192820A (ja) * 1982-05-06 1983-11-10 Mochida Pharmaceut Co Ltd 抗ウイルス作用を有する医薬組成物
NL8220205A (nl) * 1981-06-22 1983-05-02 Mochida Pharm Co Ltd Farmaceutisch preparaat met anti-virusactiviteit.
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
JPS5878796A (ja) * 1981-11-06 1983-05-12 Jujo Paper Co Ltd 熱記録体
JPS6189887A (ja) * 1984-10-09 1986-05-08 Hosokawa Katsupanshiyo:Kk 感熱熱転写用原紙
JPS61164892A (ja) * 1985-01-17 1986-07-25 Matsushita Electric Ind Co Ltd 転写型感熱記録用受像体
JPS61164893A (ja) * 1985-01-17 1986-07-25 Matsushita Electric Ind Co Ltd 転写型感熱記録用受像体
DE3661070D1 (en) * 1985-03-27 1988-12-08 Merck & Co Inc 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
JPS61188866U (US07923587-20110412-C00022.png) * 1985-05-16 1986-11-25
JPS62204988A (ja) * 1986-03-06 1987-09-09 Teijin Ltd 印刷用原紙
ZA92970B (en) * 1991-02-12 1992-10-28 Hoechst Ag Arylsulfonylureas,processes for their preparation,and their use as herbicides and growth regulators
US7262318B2 (en) 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds

Also Published As

Publication number Publication date
JPS5817167B2 (ja) 1983-04-05
GB2090136A (en) 1982-07-07
JPS58914A (ja) 1983-01-06
GB2090136B (en) 1985-02-06
JPS5781411A (en) 1982-05-21
FR2493702A1 (fr) 1982-05-14
DE3144689A1 (de) 1982-07-22

Similar Documents

Publication Publication Date Title
FR2475270B1 (US07923587-20110412-C00022.png)
FR2473093B1 (US07923587-20110412-C00022.png)
FR2473725B1 (US07923587-20110412-C00022.png)
FR2475115B1 (US07923587-20110412-C00022.png)
FR2485897B1 (US07923587-20110412-C00022.png)
FR2473981B1 (US07923587-20110412-C00022.png)
DE3153254A1 (US07923587-20110412-C00022.png)
FR2474036B1 (US07923587-20110412-C00022.png)
FR2474047B1 (US07923587-20110412-C00022.png)
FR2474476B1 (US07923587-20110412-C00022.png)
CH655498B (US07923587-20110412-C00022.png)
FR2493702B1 (US07923587-20110412-C00022.png)
FR2474808B1 (US07923587-20110412-C00022.png)
FR2474065B1 (US07923587-20110412-C00022.png)
FR2473926B1 (US07923587-20110412-C00022.png)
FR2473558B1 (US07923587-20110412-C00022.png)
FR2474867B1 (US07923587-20110412-C00022.png)
FR2473162B3 (US07923587-20110412-C00022.png)
FR2473586B1 (US07923587-20110412-C00022.png)
CH655542B (US07923587-20110412-C00022.png)
FR2492974B3 (US07923587-20110412-C00022.png)
FR2472905B1 (US07923587-20110412-C00022.png)
FR2475129B1 (US07923587-20110412-C00022.png)
FR2473044B1 (US07923587-20110412-C00022.png)
FR2475228B1 (US07923587-20110412-C00022.png)

Legal Events

Date Code Title Description
ST Notification of lapse